Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2004, p. 3162-3164, Vol. 48, No. 8
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.8.3162-3164.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
ukasiak,4 Marco Rocchi,5 Vittorio Saba,2 and Giorgio Scalise1
Institute of Infectious Diseases and Public Health, Università Politecnica delle Marche,1
Department of General Surgery, I.N.R.C.A. I.R.C.C.S., Università Politecnica delle Marche,2
Biotechnology Centre, Research Department, I.N.R.C.A. I.R.C.C.S., Ancona,3
Institute of Biomathematics, Faculty of Pharmacy, University of Urbino, Urbino, Italy,5
Faculty of Pharmacy, Medical University of Gda
sk, Gda
sk, Poland4
Received 1 April 2004/ Returned for modification 3 April 2004/ Accepted 5 April 2004
The efficacy of linezolid and temporin A in the prevention of prosthetic graft infection due to methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides was investigated in a subcutaneous rat pouch model. Linezolid and temporin A, alone or combined, greatly reduced the bacterial numbers compared to the effect with control drugs.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»